XtalPi works with collaboration partners to bring the power of ID4 to their small-molecule or macromolecule programs, creating custom solutions leveraging parts if not the entirety of the ID4 platform
In the increasingly competitive biopharmaceutical industry, discovering novel and potent drug candidates efficiently with optimal properties profile to enter the clinic could mean the difference between success and failure. XtalPi’s integrated technology platform (ID4) can assist you with all aspects of drug discovery and development.
Target identification and characterization of binding modes
Ideation exploring novel chemical space
Accurate predictions of potency and ADMET properties
Formulation strategies and synthesizability evaluation
Rapid synthesis and assays
AI-enhanced physics-based computational modeling
